Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke

M Endres, MA Moro, CH Nolte, C Dames… - Circulation …, 2022 - Am Heart Assoc
Inflammation and immune mechanisms are crucially involved in the pathophysiology of the
development, acute damage cascades, and chronic course after ischemic stroke …

Treatments in ischemic stroke: current and future

MG Mosconi, M Paciaroni - European neurology, 2022 - karger.com
Abstract Background and Aim: Despite progress made over the last 30 years, stroke is still a
leading cause of disability and mortality; likewise, its burden is expected to increase over the …

[HTML][HTML] Microglia autophagy in ischemic stroke: A double-edged sword

L Peng, G Hu, Q Yao, J Wu, Z He, BYK Law… - Frontiers in …, 2022 - frontiersin.org
Ischemic stroke (IS) is one of the major types of cerebrovascular diseases causing
neurological morbidity and mortality worldwide. In the pathophysiological process of IS …

[HTML][HTML] Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 “long haulers”

TL Rothstein - BMC neurology, 2023 - Springer
Abstract Objective COVID-19 (SARS-CoV-2) has been associated with neurological
sequelae even in those patients with mild respiratory symptoms. Patients experiencing …

[HTML][HTML] Vitamin D3 and ischemic stroke: a narrative review

W Lasoń, D Jantas, M Leśkiewicz, M Regulska… - Antioxidants, 2022 - mdpi.com
Ischemic stroke is one of the major causes of death and permanent disability worldwide. The
only efficient treatment to date is anticoagulant therapy and thrombectomy, which enable …

Incidence of epilepsy and seizures over the first 6 months after a COVID-19 diagnosis: a retrospective cohort study

M Taquet, O Devinsky, JH Cross, PJ Harrison, A Sen - Neurology, 2023 - AAN Enterprises
Background and Objectives The relationship between COVID-19 and epilepsy is uncertain.
We studied the potential association between COVID-19 and seizures or epilepsy in the 6 …

[HTML][HTML] Pathomechanisms and treatment implications for stroke in COVID-19: a review of the literature

B Stamm, D Huang, R Royan, J Lee, J Marquez… - Life, 2022 - mdpi.com
Stroke in patients with COVID-19 has received increasing attention throughout the global
COVID-19 pandemic, perhaps due to the substantial disability and mortality that can result …

Safety and outcome of revascularization treatment in patients with acute ischemic stroke and COVID-19: the global COVID-19 stroke registry

JP Marto, D Strambo, G Ntaios, TN Nguyen, R Herzig… - Neurology, 2023 - AAN Enterprises
Background and Objectives COVID-19–related inflammation, endothelial dysfunction, and
coagulopathy may increase the bleeding risk and lower the efficacy of revascularization …

[HTML][HTML] A bibliometric analysis of COVID-19 publications in neurology by using the visual mapping method

Q Zhang, J Li, L Weng - Frontiers in Public Health, 2022 - frontiersin.org
Background The characteristic symptom of coronavirus disease 2019 (COVID-19) is
respiratory distress, but neurological symptoms are the most frequent extra-pulmonary …

Effect of asymptomatic and symptomatic COVID-19 on acute ischemic stroke revascularization outcomes

D Strambo, JP Marto, G Ntaios, TN Nguyen, P Michel - Stroke, 2024 - Am Heart Assoc
BACKGROUND: The association of COVID-19 with higher bleeding risk and worse
outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the …